{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:31:14Z","timestamp":1793496674312,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.gim.2025.101556","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:51:41Z","timestamp":1755651101000},"page":"101556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["BRCA genetic testing utilization and expenditures among privately insured adults in the United States, 2013 to 2022"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1842-8334","authenticated-orcid":false,"given":"Lu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-965X","authenticated-orcid":false,"given":"Katherine","family":"Kolor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7550-6837","authenticated-orcid":false,"given":"Christine Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9887-443X","authenticated-orcid":false,"given":"Muin J.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1078-6855","authenticated-orcid":false,"given":"Scott D.","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.gim.2025.101556_bib1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN Guidelines\u00ae insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024","volume":"21","author":"Daly","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.gim.2025.101556_bib2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gim.2025.101556_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes\u2014association analysis in more than 113,000 women","volume":"384","author":"Breast Cancer Association Consortium","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.gim.2025.101556_bib4","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.gim.2025.101556_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.gim.2025.101556_bib6","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/bjc.2014.428","article-title":"The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer","volume":"111","author":"Akbari","year":"2014","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.gim.2025.101556_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaoncol.2018.6760","article-title":"Prevalence of germline variants in prostate cancer and implications for current genetic testing guidelines","volume":"5","author":"Nicolosi","year":"2019","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.gim.2025.101556_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gim.2025.101556_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41436-019-0633-8","article-title":"A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients","volume":"22","author":"LaDuca","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2025.101556_bib10","first-page":"1","article-title":"Multigene hereditary cancer panels reveal high-risk pancreatic cancer susceptibility genes","volume":"2","author":"Hu","year":"2018","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"10.1016\/j.gim.2025.101556_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkab044","article-title":"Penetrance of breast cancer susceptibility genes from the eMERGE III network","volume":"5","author":"Fan","year":"2021","journal-title":"JNCI Cancer Spectr"},{"issue":"23","key":"10.1016\/j.gim.2025.101556_bib13","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.gim.2025.101556_bib15","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2016.69.4935","article-title":"Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores","volume":"35","author":"Lecarpentier","year":"2017","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.gim.2025.101556_bib14","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.21.02112","article-title":"Cancer risks associated with BRCA1 and BRCA2 pathogenic variants","volume":"40","author":"Li","year":"2022","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.gim.2025.101556_bib16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jama.2019.8430","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"322","author":"Nelson","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.gim.2025.101556_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.23.02225","article-title":"Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology guideline","volume":"42","author":"Bedrosian","year":"2024","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.gim.2025.101556_bib18","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1200\/JCO.19.02960","article-title":"Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline","volume":"38","author":"Konstantinopoulos","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.gim.2025.101556_bib19","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","article-title":"Consensus guidelines on genetic` testing for hereditary breast cancer from the American Society of Breast Surgeons","volume":"26","author":"Manahan","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.gim.2025.101556_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/gim.2017.118","article-title":"Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014","volume":"20","author":"Chen","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2025.101556_bib21","article-title":"BRCA testing and testing results among women 18-65 years old","volume":"26","author":"Guo","year":"2022","journal-title":"Prev Med Rep"},{"issue":"6","key":"10.1016\/j.gim.2025.101556_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.amepre.2017.01.027","article-title":"Use of BRCA mutation test in the U.S., 2004-2014","volume":"52","author":"Guo","year":"2017","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.gim.2025.101556_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/cncr.32536","article-title":"BRCA testing in unaffected young women in the United States, 2006-2017","volume":"126","author":"Guo","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gim.2025.101556_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1475-6773.12612","article-title":"Adjusting health expenditures for inflation: a review of measures for health services research in the United States","volume":"53","author":"Dunn","year":"2018","journal-title":"Health Serv Res"},{"issue":"4","key":"10.1016\/j.gim.2025.101556_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41431-021-01011-8","article-title":"30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes","volume":"30","author":"Woodward","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.gim.2025.101556_bib26","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41431-025-01801-4","article-title":"Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014-2023","volume":"33","author":"Schilling","year":"2025","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.gim.2025.101556_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.breast.2023.01.001","article-title":"A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis","volume":"67","author":"Li","year":"2023","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.gim.2025.101556_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jamaoncol.2022.5481","article-title":"Rates of routine cancer screening and diagnosis before vs after the COVID-19 pandemic","volume":"9","author":"Oakes","year":"2023","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.gim.2025.101556_bib29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jgc4.1792","article-title":"The impact of converting to telehealth for cancer genetic counseling and testing during the COVID-19 pandemic","volume":"33","author":"Proussaloglou","year":"2024","journal-title":"J Genet Couns"},{"issue":"4","key":"10.1016\/j.gim.2025.101556_bib30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jgc4.1365","article-title":"Transition to telephone genetic counseling services during the COVID-19 pandemic","volume":"30","author":"Shannon","year":"2021","journal-title":"J Genet Couns"},{"issue":"5","key":"10.1016\/j.gim.2025.101556_bib31","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jgc4.1507","article-title":"Telehealth genetic services during the COVID-19 Pandemic: implementation and patient experiences across multiple specialties in Nebraska","volume":"30","author":"Rezich","year":"2021","journal-title":"J Genet Couns"},{"issue":"15","key":"10.1016\/j.gim.2025.101556_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6615a1","article-title":"BRCA genetic testing and receipt of preventive interventions among women aged 18-64 years with employer-sponsored health insurance in nonmetropolitan and metropolitan areas\u2014United States, 2009-2014","volume":"66","author":"Kolor","year":"2017","journal-title":"MMWR Surveill Summ"},{"issue":"6","key":"10.1016\/j.gim.2025.101556_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41431-021-01022-5","article-title":"A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease","volume":"30","author":"Best","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"19","key":"10.1016\/j.gim.2025.101556_bib34","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force recommendation statement","volume":"325","author":"United States Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.gim.2025.101556_bib35","article-title":"Genetic\/familial high-risk assessment: breast and ovarian. version 3.2013","author":"Daly","year":"2013","journal-title":"Journal of the National Comprehensive Cancer Network"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025002035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025002035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:27:34Z","timestamp":1793496454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360025002035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1098360025002035"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2025.101556","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRCA genetic testing utilization and expenditures among privately insured adults in the United States, 2013 to 2022","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2025.101556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"101556"}}